hg_143703.1

Basic information about the TSS

---

TSS ID: hg_143703.1 Species: human Chr: chr14		Start: 65101671 End: 65101690 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000553951.1 AK303412 Distance: 0 GeneID: 4149 HGNC/MGI_ID: HGNC:6913 UniProt_ID: B4E0K3

Gene_name: MYC associated factor X Gene_symbol: MAX Gene_synonyms: bHLHd4 bHLHd5 bHLHd6 bHLHd7 bHLHd8 Gene_source: HGNC:6913

TATA-Box annotation

---

Distance to TSS:	836
Nearest PromoterID:	NM_145112
Entrez ID:	4149
Nearest Unigene:	Hs.285354
Nearest Refseq:	NM_002382
Nearest Ensembl:	ENSG00000125952
Gene Name:	MYC associated factor X
Gene Alias:	bHLHd4
Gene Description:	MYC associated factor X
Gene Type:	protein-coding
CpG%:	0.05
GC%:	0.542289
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MAX p2@MAX p3@MAX p4@MAX p5@MAX p6@MAX
Sample		p1@MAX	p2@MAX	p3@MAX	p4@MAX	p5@MAX	p6@MAX
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	47.73	5.84	0.58	0.00	0.39	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	42.08	5.06	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	44.75	4.24	0.19	0.00	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	38.67	3.12	0.42	0.00	0.42	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	46.57	4.95	1.12	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	53.30	4.85	0.39	0.00	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.91	3.92	0.87	0.00	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	41.42	5.81	0.24	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	35.05	4.92	0.43	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	30.72	2.32	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	33.55	4.45	0.40	0.00	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	41.47	2.03	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	27.08	3.06	2.90	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	32.33	2.71	3.46	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	32.93	3.07	2.63	0.00	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.89	3.77	3.27	0.25	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	29.05	4.15	2.62	0.00	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.78	4.22	3.37	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	30.92	1.07	2.67	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.67	2.86	2.86	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	26.86	3.34	3.47	0.00	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.83	4.66	2.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	26.11	2.20	3.75	0.00	0.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	18.69	2.67	3.15	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.57	4.13	0.52	0.00	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	19.94	3.80	2.22	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	18.68	6.59	4.40	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	29.47	5.19	0.94	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	25.20	2.10	2.75	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.98	3.26	1.45	0.18	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.61	3.77	2.30	0.21	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.95	2.34	2.54	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.58	4.22	3.80	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	41.40	4.95	2.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.88	3.93	1.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	26.44	2.68	2.68	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	27.18	3.47	2.86	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	22.57	4.43	1.21	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.15	4.32	2.43	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	23.05	4.08	1.44	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.11	4.94	1.88	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	29.86	6.00	2.20	0.15	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.19	3.59	1.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.13	3.15	1.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	26.50	3.61	1.61	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	25.59	6.05	2.33	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.71	3.12	1.92	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.97	3.58	2.98	0.30	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.78	5.03	1.68	0.00	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	28.11	3.24	3.03	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.58	3.89	2.87	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	16.23	3.34	1.78	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	573.68	125.93	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.03	2.84	1.77	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.89	1.99	3.31	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	96.48	9.23	9.23	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	37.20	8.27	4.59	0.00	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.96	1.94	1.62	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	6.74	1.61	1.61	0.32	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	22.32	2.83	3.14	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.81	0.00	2.12	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	13.46	3.36	3.36	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	66.88	10.35	3.98	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.59	3.06	3.06	0.00	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	5.20	0.97	1.95	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.39	3.19	0.00	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	614.23	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	552.82	86.87	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	2.44	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.41	2.48	0.99	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	1.88	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.28	0.33	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.57	0.93	0.31	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.95	1.83	1.22	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	69.06	10.29	2.06	0.00	0.32	0.48
Adipocyte - breast, donor2	11327-117E4	41.07	6.74	1.44	0.00	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	65.27	14.12	2.29	0.13	0.38	0.25
Adipocyte - omental, donor2	11474-119C7	24.67	5.23	2.24	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	34.50	8.37	1.00	0.00	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	42.75	9.57	0.64	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	3.30	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	39.29	5.87	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	40.32	5.39	0.70	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	65.52	12.71	1.96	0.00	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	41.95	9.01	1.54	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	50.46	8.36	0.56	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	51.73	9.99	2.35	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	64.51	7.80	1.21	0.00	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	55.51	8.71	1.29	0.00	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	35.72	8.53	0.00	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	39.51	5.56	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	32.86	2.91	0.00	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	40.19	6.78	1.00	0.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	35.67	5.89	0.65	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	32.27	4.57	0.91	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	46.85	9.06	0.22	0.00	0.00	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	32.99	4.30	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	46.78	7.02	0.90	0.18	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	38.49	8.37	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	50.54	6.57	1.44	0.00	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	35.36	9.50	2.06	0.23	0.23	0.11
Anulus Pulposus Cell, donor2	11463-119B5	16.41	4.90	2.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.32	7.19	2.70	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.44	6.95	2.60	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	8.56	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	23.02	5.98	1.49	0.00	1.20	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	25.29	10.12	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	19.14	2.64	0.66	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.22	4.22	0.32	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.27	7.28	0.97	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.91	4.16	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.48	7.16	1.51	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.77	5.81	0.00	0.73	0.73	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	0.00	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	37.40	5.44	3.13	0.00	0.33	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	6.82	1.36	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.06	1.81	0.75	0.00	0.15	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.15	3.75	3.21	0.00	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	27.02	4.72	1.32	0.00	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	24.06	4.01	2.14	0.27	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	7.80	5.85	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.86	5.47	2.32	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	4.80	3.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	10.62	3.54	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	31.22	4.63	2.06	0.00	0.51	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	25.73	5.34	3.88	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.66	6.45	2.28	0.76	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	4.85	7.27	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.81	6.84	1.14	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.36	5.13	2.14	0.00	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	18.84	4.13	0.77	0.26	0.26	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	24.40	4.69	1.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	34.73	6.75	0.96	0.00	0.32	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	21.40	4.28	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.89	4.68	0.58	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.48	2.71	0.30	0.00	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	2.38	2.38	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	20.34	8.14	2.54	0.00	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.29	4.58	0.51	0.00	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	1.91	3.18	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.58	8.20	0.86	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.77	5.93	1.48	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.85	5.22	2.32	0.00	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	19.84	6.61	1.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.56	4.41	0.68	0.00	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	12.68	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.30	4.07	2.36	0.00	0.64	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.24	4.21	1.20	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	20.41	6.56	2.92	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	31.95	4.14	1.61	0.00	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	14.49	3.05	1.27	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	34.27	7.84	2.68	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.70	5.20	0.92	0.31	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.03	8.13	2.87	0.48	0.48	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	25.94	4.66	2.22	0.00	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	1.53	3.05	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	25.48	5.54	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	33.63	5.56	2.12	0.00	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	23.62	5.09	1.82	0.00	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	55.27	14.12	2.33	0.12	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	29.10	9.76	1.03	0.34	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	34.61	9.02	2.10	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	31.37	4.18	2.79	0.00	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	32.35	7.12	0.32	0.00	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	26.25	5.97	0.60	0.00	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	82.92	15.14	0.80	0.00	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	82.31	17.79	0.50	0.00	0.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	79.20	16.16	0.68	0.34	0.11	0.23
Basophils, donor1	12241-129G9	131.81	17.52	21.71	1.83	3.40	15.69
Basophils, donor2	12242-129H1	97.05	15.51	21.29	0.00	2.53	10.46
Basophils, donor3	12243-129H2	57.18	11.91	12.20	0.15	1.62	2.79
Bronchial Epithelial Cell, donor1	11511-119G8	31.91	5.39	0.22	0.22	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	24.69	1.83	0.46	0.00	0.46	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	28.24	6.28	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	34.31	4.57	0.62	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	27.17	2.99	0.92	0.00	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	20.15	2.88	0.36	0.00	0.00	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	94.91	15.46	4.02	0.10	0.62	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	90.13	16.54	4.89	0.00	0.93	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	87.30	19.51	11.19	4.16	3.20	3.84
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	41.37	62.05	0.00	10.34	20.68
CD14+ Monocytes, donor1	11224-116B9	54.10	10.71	14.09	0.56	1.69	2.82
CD14+ Monocytes, donor2	11305-117B9	40.28	9.47	18.93	0.37	1.30	3.53
CD14+ Monocytes, donor3	11381-118B4	50.93	8.56	14.05	0.22	1.76	3.73
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	110.67	11.60	7.93	0.57	0.85	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	105.76	12.89	11.37	0.00	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	139.06	9.20	10.85	0.33	1.31	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	62.45	8.82	19.08	0.14	1.59	2.60
CD14+ monocytes - mock treated, donor2	11873-125C1	51.30	6.64	14.18	0.30	2.41	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	62.30	10.19	16.35	0.47	2.84	2.61
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	40.34	6.86	9.54	0.00	0.84	2.18
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	36.99	4.42	8.83	0.00	0.55	3.04
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	40.16	5.95	8.93	0.25	1.98	1.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	48.95	4.70	10.96	0.00	1.17	2.35
CD14+ monocytes - treated with BCG, donor2	11870-125B7	51.46	7.30	9.26	0.00	1.78	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	62.46	9.36	16.32	0.00	2.83	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	34.18	5.85	9.83	0.00	0.47	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	53.86	7.92	15.31	0.53	0.53	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	7.77	18.86	0.00	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	46.56	5.95	16.51	0.45	1.19	3.42
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	31.13	5.19	9.98	0.20	0.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	53.92	7.29	9.58	0.21	0.83	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	40.49	5.26	8.24	0.00	0.69	5.03
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	43.88	8.82	13.35	0.00	1.13	2.94
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	41.46	4.36	11.78	0.00	0.87	3.06
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	52.18	7.80	8.07	0.27	1.34	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	73.27	9.07	19.71	0.17	2.09	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	65.23	8.42	18.94	0.00	2.10	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	28.11	4.96	7.72	0.18	0.73	1.84
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	28.18	6.34	6.69	0.00	1.06	3.17
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	42.56	3.95	6.14	0.00	0.44	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	59.81	5.93	12.21	0.17	1.57	2.96
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	46.83	6.32	11.52	0.37	1.86	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	72.64	10.35	19.83	0.00	2.37	3.66
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	45.04	8.19	9.83	0.00	0.41	3.69
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	35.23	7.19	10.43	0.00	1.16	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	47.79	7.89	10.67	0.23	0.46	2.09
CD14+CD16+ Monocytes, donor1	11789-124B7	54.49	8.94	5.89	0.00	1.09	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	61.91	9.70	9.01	0.00	0.69	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	52.64	8.01	5.42	0.00	0.22	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	119.13	18.84	21.02	0.00	1.09	2.96
CD14+CD16- Monocytes, donor2	11799-124C8	67.41	13.97	18.16	0.17	1.22	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	97.66	16.28	22.07	0.45	2.45	2.45
CD14-CD16+ Monocytes, donor1	11790-124B8	56.39	10.21	2.55	0.00	0.00	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	59.72	9.66	2.85	0.22	1.10	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	51.58	9.69	2.74	0.00	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	22.36	12.19	0.00	6.10	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	131.53	18.98	12.20	1.36	0.68	6.78
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	115.99	13.46	14.50	0.00	3.11	5.18
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	100.74	18.12	13.33	0.53	0.53	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	145.81	21.44	13.40	0.00	1.07	7.50
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	134.77	16.85	7.02	0.00	4.21	9.13
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	120.01	13.33	16.47	0.00	0.00	4.71
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	127.87	23.73	19.77	0.00	2.64	5.27
CD19+ B Cells, donor1	11544-120B5	67.40	8.22	18.08	2.47	2.47	7.40
CD19+ B Cells, donor2	11624-122B4	70.37	13.78	18.14	0.73	2.90	6.53
CD19+ B Cells, donor3	11705-123B4	85.82	13.63	24.74	1.01	5.05	4.54
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	97.38	28.28	2.83	0.40	0.00	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	71.11	23.97	0.80	0.00	0.00	2.00
CD34+ Progenitors, donor1	11545-120B6	75.30	16.06	20.08	2.01	5.02	7.03
CD34+ Progenitors, donor2	11625-122B5	96.63	19.10	28.65	3.93	4.49	12.36
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	73.27	15.03	10.52	2.25	0.38	5.26
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	85.46	18.26	10.82	2.71	0.90	4.74
CD4+ T Cells, donor1	11225-116C1	162.82	24.28	71.77	2.50	18.92	13.21
CD4+ T Cells, donor2	11306-117C1	99.82	21.43	36.74	2.45	11.63	8.57
CD4+ T Cells, donor3	11382-118B5	89.67	22.57	38.73	1.83	6.40	9.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	107.97	15.31	20.16	2.30	3.57	6.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	122.41	12.58	21.11	4.94	5.17	5.39
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	114.12	16.10	17.25	6.61	5.75	8.34
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	170.20	34.61	36.51	4.27	15.17	6.16
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	166.45	25.28	47.76	3.51	14.05	14.75
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	108.78	23.07	42.85	0.00	9.89	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	86.42	14.31	15.17	1.73	2.60	5.35
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	76.77	11.35	8.64	1.86	1.69	2.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	64.97	10.80	8.38	1.77	0.97	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	109.38	19.28	29.14	2.24	11.21	9.86
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	95.03	19.57	35.64	4.89	9.78	13.63
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	94.16	18.48	43.56	4.40	14.52	11.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	89.39	19.82	21.08	2.95	9.28	7.59
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	73.55	11.43	12.05	1.04	3.95	6.03
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.45	10.02	12.03	1.00	3.01	6.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	168.33	23.66	57.11	3.26	10.88	5.71
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	147.39	32.16	54.67	4.82	12.33	6.43
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	130.91	25.11	35.86	1.79	10.76	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	97.54	17.62	17.43	1.67	4.26	4.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	81.45	11.48	11.48	2.60	4.12	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	70.19	12.19	9.04	1.68	2.94	3.78
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	107.69	17.19	27.30	0.51	10.62	12.13
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	103.98	23.40	28.16	1.30	6.93	11.26
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	117.23	27.46	33.99	7.41	10.90	7.84
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	200.42	35.63	32.66	2.97	7.42	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	148.63	30.47	23.08	4.62	1.85	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	128.42	19.54	20.94	1.40	4.19	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	209.36	40.15	36.00	2.22	4.15	6.92
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	224.53	42.45	36.32	3.93	7.85	10.31
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	227.92	26.18	27.72	7.70	1.54	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	209.86	29.72	23.28	2.15	5.73	4.66
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	189.74	33.24	24.93	2.77	0.00	5.54
CD8+ T Cells, donor1	11226-116C2	106.08	23.25	31.43	2.29	5.24	4.58
CD8+ T Cells, donor2	11307-117C2	75.84	13.52	22.90	1.50	4.51	4.13
CD8+ T Cells, donor3	11383-118B6	100.49	19.19	29.29	2.02	7.83	6.82
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	14.22	6.42	0.23	0.00	0.23	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.02	4.55	0.24	0.00	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.78	3.56	0.82	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.72	5.70	0.60	0.00	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.92	2.88	0.72	0.00	0.72	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	12.73	4.09	0.23	0.00	0.00	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.34	2.61	1.09	0.00	0.65	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	14.74	2.63	0.00	0.00	0.00	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.01	2.35	0.70	0.23	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	14.49	2.72	0.60	0.30	0.00	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.27	2.03	0.58	0.29	0.00	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	13.32	5.86	0.80	0.00	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	9.19	0.88	1.31	0.00	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.12	2.28	0.00	0.46	0.00	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.93	2.24	0.75	0.00	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14.05	6.48	0.72	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.98	5.47	0.29	0.00	0.00	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.44	5.66	1.18	0.24	0.24	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	15.21	5.39	1.27	0.00	0.32	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.38	3.69	0.62	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.79	4.17	1.60	0.00	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.00	5.74	0.38	0.38	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.06	1.97	1.58	0.00	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	3.78	0.76	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	25.69	9.64	1.61	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.18	2.10	4.20	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	18.03	5.01	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	31.07	7.31	7.31	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	23.22	4.94	0.99	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	39.25	7.05	1.89	0.00	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	29.47	7.63	1.73	0.00	0.35	0.69
Chondrocyte - de diff, donor2	11338-117F6	29.14	7.46	1.42	0.00	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	32.20	6.03	3.41	0.00	0.23	0.11
Chondrocyte - re diff, donor2	11339-117F7	85.05	15.22	2.69	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	48.53	4.45	2.02	0.00	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	42.92	9.30	2.18	0.23	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	31.00	5.99	1.07	0.00	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	28.32	6.28	1.95	0.00	0.27	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	74.64	19.81	7.52	0.18	1.01	1.01
Corneal Epithelial Cells, donor1	11526-119I5	39.30	6.15	0.44	0.00	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	18.20	5.69	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	34.25	5.11	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	45.07	7.43	1.16	0.00	0.00	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	42.26	7.25	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	69.01	17.25	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	35.85	6.80	1.30	0.00	0.00	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	92.58	14.35	9.22	2.05	2.39	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	86.18	10.45	6.53	2.61	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	104.53	13.55	8.23	4.36	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	55.70	8.51	4.00	0.67	0.33	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	35.21	4.11	2.93	0.00	0.59	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	42.99	7.64	2.26	0.00	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	46.00	8.26	5.50	0.00	0.79	0.79
Endothelial Cells - Artery, donor1	11264-116G4	31.71	3.49	1.45	0.58	0.87	1.45
Endothelial Cells - Artery, donor2	11341-117F9	34.59	5.88	3.53	0.00	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	41.72	9.12	2.98	0.53	0.00	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	57.85	9.53	1.77	1.11	0.00	1.77
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.77	10.04	1.52	0.61	0.00	2.74
Endothelial Cells - Lymphatic, donor3	11393-118C7	51.59	5.64	1.13	0.28	0.56	2.26
Endothelial Cells - Microvascular, donor1	11265-116G5	31.20	5.35	5.94	0.59	0.30	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	29.68	7.81	1.56	0.52	1.04	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	29.21	4.25	4.96	1.13	0.71	2.13
Endothelial Cells - Thoracic, donor1	11266-116G6	54.82	8.00	3.20	0.80	0.80	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	32.50	5.77	1.05	0.00	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	63.86	9.44	2.98	1.24	0.62	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	46.49	5.87	1.96	0.43	0.00	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	46.90	6.59	1.47	0.24	0.12	0.61
Endothelial Cells - Vein, donor1	11267-116G7	32.99	6.83	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	34.23	9.78	2.10	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	36.27	7.69	3.30	0.31	0.63	1.41
Eosinophils, donor1	12244-129H3	198.21	30.49	30.49	15.25	0.00	45.74
Eosinophils, donor2	12245-129H4	368.01	34.66	70.96	1.65	18.15	8.25
Eosinophils, donor3	12246-129H5	274.65	17.83	39.24	0.00	0.00	10.70
Esophageal Epithelial Cells, donor1	11507-119G4	23.94	2.93	0.00	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	35.71	6.16	3.28	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.55	3.28	0.88	0.00	0.33	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.78	4.12	1.63	0.11	0.11	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	55.30	10.67	2.18	0.24	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	38.76	5.05	0.55	0.00	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	43.03	5.48	1.58	0.11	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.34	3.95	1.32	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	40.20	8.97	0.33	0.00	0.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	33.57	10.89	1.36	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	31.08	7.58	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	36.27	5.68	2.52	0.00	0.63	0.32
Fibroblast - Cardiac, donor4	11452-119A3	62.14	7.58	3.64	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	28.05	4.44	2.41	0.13	0.00	0.89
Fibroblast - Cardiac, donor6	11460-119B2	28.50	8.03	1.21	0.15	0.30	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	66.19	9.65	3.48	0.13	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	31.06	8.63	1.73	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	2.93	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	53.05	17.76	0.92	0.23	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	58.51	8.14	7.29	0.17	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	35.92	6.10	0.23	0.00	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	46.22	10.38	2.36	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	35.54	7.01	1.21	0.00	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	26.45	6.56	0.34	0.00	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	23.90	7.85	0.87	0.00	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	30.70	8.93	0.49	0.00	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	42.27	10.62	0.83	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	45.33	9.17	3.41	0.00	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	29.91	8.30	1.45	0.13	0.53	0.13
Fibroblast - Gingival, donor3	11394-118C8	37.80	7.83	0.58	0.10	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	64.41	10.39	2.08	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	42.47	5.11	1.59	0.00	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	36.48	6.55	0.78	0.00	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	31.51	9.60	1.08	0.00	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.94	11.29	1.06	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.51	6.73	1.46	0.00	0.44	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	50.04	8.04	1.77	0.00	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	37.30	7.57	1.32	0.11	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	47.10	5.72	5.43	0.00	0.59	0.15
Fibroblast - Lung, donor1	11270-116H1	28.55	2.72	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	23.87	4.48	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	33.77	6.96	1.48	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	104.13	29.99	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	29.37	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	32.19	5.88	0.56	0.00	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	100.27	18.27	1.22	0.00	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	7.99	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	71.48	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	40.73	11.64	0.78	0.00	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	31.25	9.56	0.76	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	59.06	11.32	1.22	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	28.62	6.49	0.76	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	36.99	6.75	1.08	0.00	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.90	7.54	1.86	0.00	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	33.27	7.63	1.88	0.11	0.11	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	71.52	13.61	2.24	0.00	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	16.04	0.67	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	30.44	3.95	0.40	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	24.21	5.95	1.39	0.00	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	32.68	8.53	0.89	0.00	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.95	5.32	2.17	0.00	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	15.64	6.62	0.00	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	55.60	10.26	1.73	0.11	0.22	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	25.05	7.09	0.25	0.00	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	39.87	8.70	1.80	0.00	0.49	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	27.07	7.22	0.60	0.00	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	45.21	11.45	1.31	0.00	0.10	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.71	8.16	1.51	0.00	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	57.58	8.37	2.40	0.08	0.25	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	67.18	10.77	3.76	0.17	0.51	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.36	4.27	0.00	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	40.80	11.40	1.49	0.00	0.11	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	29.01	7.93	0.51	0.00	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	40.62	6.27	2.82	0.00	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	42.71	3.49	0.87	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	50.27	4.85	0.69	0.17	0.35	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	60.90	4.68	0.52	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	61.83	7.15	1.02	0.26	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	14.55	6.89	1.53	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.23	5.74	1.91	0.00	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.95	9.70	1.14	0.29	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	25.09	8.00	1.65	0.55	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.86	10.27	8.22	1.14	1.14	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	21.00	5.75	1.19	0.59	0.20	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	20.62	7.67	2.11	0.53	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	19.24	5.87	3.59	1.30	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	29.63	7.96	1.33	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	32.22	8.20	1.27	0.57	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	32.76	7.88	1.85	0.12	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.92	6.45	1.34	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.79	8.42	1.86	0.25	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	35.30	7.61	1.94	0.69	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	36.19	5.69	1.42	1.02	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	43.81	7.07	2.97	0.46	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	31.02	7.10	1.99	0.50	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	38.25	6.12	3.28	0.87	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	41.96	6.80	2.66	0.30	0.89	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.99	6.99	2.07	0.64	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	32.40	6.03	1.56	0.67	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	40.93	5.65	1.61	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.34	8.48	1.53	0.34	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.99	9.67	3.55	0.27	0.44	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	62.02	8.22	3.64	0.00	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	56.70	8.20	2.73	0.17	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	35.52	6.97	1.44	0.00	0.11	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.57	8.24	2.25	0.17	0.17	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.74	8.17	1.63	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	40.44	6.81	1.24	0.41	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	38.51	8.07	1.50	0.35	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	43.36	5.50	1.50	0.00	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	36.59	4.85	2.20	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	44.28	6.64	1.35	0.25	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	38.42	7.62	1.62	0.00	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.49	4.81	2.57	0.00	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	30.61	5.21	1.99	0.19	0.19	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	38.75	3.64	2.06	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	46.53	6.08	2.13	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	35.44	7.11	1.46	0.00	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.93	5.05	3.29	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	37.03	5.33	1.12	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	29.35	7.59	1.94	0.09	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.62	5.08	1.87	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	34.12	5.20	1.22	0.15	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	33.16	6.87	1.42	0.00	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.99	5.42	2.44	0.54	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.56	7.37	1.66	0.00	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	40.79	5.26	2.63	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	54.55	9.92	4.96	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	40.63	6.99	1.98	0.26	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	39.54	4.64	1.21	0.00	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	109.54	19.82	7.12	0.25	0.76	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	67.28	14.73	1.19	1.99	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	44.53	9.24	1.69	0.92	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	44.60	12.48	1.84	1.43	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.01	4.38	0.00	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	13.56	2.54	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	13.84	5.53	1.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	2.47	4.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	26.30	6.96	1.55	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	0.00	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	5.22	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	22.13	4.56	0.33	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	29.24	6.18	2.06	0.82	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	21.53	6.15	1.40	0.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	21.57	4.25	0.65	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	18.45	5.03	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.27	6.36	2.23	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	23.78	3.06	2.72	0.00	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	16.71	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	34.93	6.87	1.72	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.24	3.85	1.78	0.30	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	3.39	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.44	7.04	1.24	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	22.32	6.44	0.92	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	18.84	3.84	0.00	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	18.58	6.19	2.61	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	2.68	2.01	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	33.13	7.71	0.77	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	34.58	7.53	1.37	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	16.04	4.72	1.42	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	24.14	4.83	1.21	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	18.31	3.56	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.54	5.98	0.80	0.00	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	28.12	7.40	1.97	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	22.43	4.72	2.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.84	4.67	0.00	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	30.72	6.14	0.88	0.44	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	25.43	3.39	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	25.67	2.98	1.19	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.90	5.82	1.94	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	49.08	3.42	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	43.24	4.57	2.49	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	43.85	12.37	2.25	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	32.67	3.81	2.54	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.48	5.01	0.84	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.70	8.24	0.46	0.00	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.70	8.27	0.17	0.00	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	25.48	10.92	0.46	0.00	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	34.76	7.21	0.44	0.00	0.11	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.29	9.24	0.21	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	26.26	9.04	0.00	0.00	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	30.01	6.97	0.25	0.00	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	30.02	9.61	0.69	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.71	4.81	0.32	0.00	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	38.05	5.60	2.24	1.12	0.56	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	38.95	8.22	2.16	0.00	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	41.97	10.23	3.53	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	36.33	6.54	2.18	1.45	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	23.08	3.32	1.05	0.00	0.52	0.17
Hepatocyte, donor1	11523-119I2	25.42	3.63	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	30.17	5.39	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	34.36	7.98	1.84	1.23	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	78.98	9.79	7.18	2.61	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	78.65	13.63	1.75	0.52	1.05	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	35.54	7.00	1.65	0.00	0.27	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	11.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	7.51	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	7.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	4.87	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	5.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	29.12	17.21	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	8.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.90	6.93	0.63	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	27.84	4.64	0.00	0.00	1.55	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	21.97	9.04	0.65	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	4.83	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	34.22	4.89	0.00	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	23.51	8.40	1.68	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.90	7.23	0.00	0.00	0.00	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	4.62	0.92	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	2.83	0.00	0.00	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	18.14	3.63	0.00	0.91	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	20.45	5.38	0.00	0.00	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	3.81	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	16.58	8.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	12.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	22.14	5.71	0.00	0.00	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	20.06	5.25	0.93	0.00	0.31	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	5.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	12.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.95	4.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	6.64	4.43	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	26.16	5.23	0.00	0.00	0.87	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	8.53	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	19.40	6.93	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	8.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	6.44	0.92	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	9.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	6.21	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	28.55	6.34	1.06	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	52.88	7.34	1.31	0.16	0.16	0.16
Keratinocyte - epidermal, donor2	11349-117G8	26.35	3.51	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	37.67	4.16	0.38	0.00	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	49.15	5.90	0.57	0.00	0.23	0.11
Keratocytes, donor1	11527-119I6	69.45	20.63	0.69	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	28.12	16.41	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	31.81	5.93	0.20	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	149.46	17.58	2.20	0.00	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	29.13	6.47	3.24	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	47.98	10.50	3.81	0.00	0.35	0.23
Lens Epithelial Cells, donor3	11690-122I7	59.74	8.27	2.02	0.10	0.50	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	44.47	5.45	5.10	0.95	0.95	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	25.95	6.42	4.47	1.12	1.40	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	35.58	6.30	4.56	0.79	0.79	3.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.05	5.38	3.76	0.54	0.54	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	34.35	4.10	3.47	0.63	0.00	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	36.55	5.28	4.96	0.97	0.43	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.16	6.16	2.87	0.41	0.41	2.46
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.30	3.29	4.55	0.25	0.00	3.03
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	33.78	4.64	5.21	0.42	0.84	2.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	24.52	6.33	4.75	0.40	0.40	3.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	34.12	6.59	5.23	0.97	0.19	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	26.29	4.81	4.26	0.56	0.56	2.78
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.51	3.83	3.48	0.35	0.35	2.09
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.05	4.77	3.82	0.48	0.24	2.86
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.94	5.36	4.40	1.24	0.41	1.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	31.10	6.78	3.39	0.00	1.85	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.94	3.43	4.05	0.62	0.62	2.49
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	40.44	4.94	5.86	1.28	0.55	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	24.68	2.30	4.61	0.66	0.33	2.63
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	29.29	5.86	2.05	1.17	0.29	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	38.83	4.23	6.72	1.24	1.00	3.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	24.25	3.88	1.94	0.48	0.97	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	26.93	5.39	4.58	0.54	0.27	3.77
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	36.94	5.15	6.06	0.45	0.76	2.57
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	26.44	4.67	4.15	0.52	0.52	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	32.87	6.07	6.49	0.42	0.21	3.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	30.38	3.91	4.51	1.05	0.60	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.15	5.50	5.50	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	32.36	5.64	4.89	0.94	0.00	2.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	38.06	6.36	7.00	0.64	0.74	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	26.17	5.33	0.97	0.97	0.00	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	34.73	6.62	3.31	0.33	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	34.19	4.21	6.19	0.50	0.25	3.10
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	39.98	4.81	5.92	2.59	0.00	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	33.60	4.45	3.71	0.00	0.99	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	27.91	6.87	5.91	0.55	0.69	2.20
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	31.52	5.15	3.86	0.96	0.32	2.25
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.65	5.48	6.39	0.30	1.22	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.15	5.46	6.72	0.56	0.56	2.10
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	33.42	6.76	2.84	0.36	1.07	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.66	1.94	3.88	1.94	0.00	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	37.66	5.91	7.00	0.47	0.47	2.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	37.24	6.09	3.22	0.36	1.07	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	36.59	5.88	3.92	0.98	0.65	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	38.37	6.36	4.71	1.41	0.94	3.30
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	49.01	7.43	5.45	0.87	0.50	2.85
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.45	2.56	6.15	0.77	0.51	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	29.54	3.58	4.77	0.90	1.19	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	36.26	11.33	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	36.06	10.74	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.20	12.62	0.00	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	38.50	13.12	1.27	0.00	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	25.32	3.52	1.41	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	30.82	8.41	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	31.95	8.76	0.52	0.00	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	28.55	8.33	2.38	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	40.04	12.67	1.13	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	33.15	8.72	1.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.51	8.55	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	57.85	16.12	1.08	0.00	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	39.54	8.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	32.46	10.94	0.35	0.00	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.98	5.33	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	36.17	13.75	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	38.69	8.80	0.27	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	42.51	11.71	0.57	0.00	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	45.40	10.43	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.85	10.60	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	43.52	11.87	1.25	0.00	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	33.07	11.21	0.56	0.00	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	38.12	11.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.58	13.64	1.74	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	33.18	11.66	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	39.28	4.98	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	40.65	14.14	1.77	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	35.03	9.59	0.37	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	11.51	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	49.50	13.43	1.54	0.00	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	45.29	8.49	1.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	37.74	9.03	2.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	39.77	15.82	0.45	0.00	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	40.93	13.64	2.15	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	42.57	10.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	40.50	15.61	1.49	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	34.46	10.77	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	35.11	11.99	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	44.65	10.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	40.42	10.26	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	30.57	6.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	37.81	12.03	1.72	0.00	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	37.04	12.88	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	35.01	8.75	3.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	50.75	11.11	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	62.80	11.63	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	47.60	6.35	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	31.21	11.60	1.60	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	45.07	10.90	2.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	41.39	16.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	47.35	11.35	1.97	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	10.35	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	44.75	13.07	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	45.51	13.97	1.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	39.59	18.93	1.72	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	48.54	13.81	1.78	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	47.71	14.08	1.96	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	38.92	9.24	1.98	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	47.74	11.42	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	56.88	18.38	1.75	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.93	10.62	1.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	34.01	10.60	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	40.50	15.43	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.01	11.65	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.41	12.98	1.44	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	41.74	14.31	0.00	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	33.42	13.98	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	49.11	8.99	0.69	0.00	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	50.54	13.30	1.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	42.35	12.91	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	41.12	16.33	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	45.95	14.58	1.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	46.38	12.79	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	43.10	12.64	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	53.48	12.34	2.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	52.34	14.85	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	49.37	15.32	1.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	59.49	15.39	1.25	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	64.21	15.66	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	45.51	12.94	2.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	55.29	19.98	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	67.57	12.04	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	35.82	10.69	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	66.27	21.01	2.42	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	57.82	22.94	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	40.90	17.78	0.89	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	53.57	14.82	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	42.18	17.64	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	43.77	9.30	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	52.56	14.25	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	55.89	18.20	1.56	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	43.77	14.59	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	24.94	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	74.76	7.75	2.96	0.00	0.68	0.46
Macrophage - monocyte derived, donor2	11313-117C8	43.86	8.62	0.92	0.00	0.37	0.37
Macrophage - monocyte derived, donor3	11389-118C3	51.25	8.00	4.33	0.00	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	40.89	3.72	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	47.69	7.61	1.27	0.00	0.48	0.48
Mallassez-derived cells, donor3	11930-125I4	48.51	5.84	1.67	0.42	0.42	0.14
Mammary Epithelial Cell, donor1	11273-116H4	48.03	6.98	0.80	0.10	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	33.30	6.08	0.87	0.00	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	29.68	4.74	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	149.82	29.83	10.85	2.03	2.03	8.81
Mast cell, donor1	11563-120D6	79.92	18.60	4.43	0.76	0.54	2.92
Mast cell, donor2	11565-120D8	162.26	37.74	18.72	1.78	3.86	10.10
Mast cell, donor3	11566-120D9	167.94	35.79	18.01	0.90	2.25	20.94
Mast cell, donor4	11567-120E1	185.98	36.70	14.54	1.60	2.66	13.83
Mast cell, expanded and stimulated, donor5	11940-126A5	77.74	18.08	3.88	0.55	0.44	1.77
Mast cell, expanded and stimulated, donor8	11942-126A7	53.12	11.67	9.92	2.33	0.58	3.50
Mast cell, expanded, donor5	11939-126A4	64.01	15.37	2.18	0.57	0.34	1.49
Mast cell, expanded, donor8	11941-126A6	77.99	14.23	4.35	1.17	0.33	11.38
Melanocyte - dark, donor1	11502-119F8	48.16	4.38	4.08	0.40	0.30	3.08
Melanocyte - dark, donor2	11582-120F7	22.84	3.11	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	66.94	7.97	1.67	0.00	0.22	0.07
Melanocyte - light, donor1	11274-116H5	58.53	8.46	2.59	0.00	0.47	0.24
Melanocyte - light, donor2	11351-117H1	51.18	6.82	4.78	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.95	6.94	2.60	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	48.31	7.39	0.10	0.00	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	63.20	5.11	2.15	0.00	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	84.91	9.37	2.41	0.00	0.27	0.00
Meningeal Cells, donor1	11493-119E8	78.41	23.94	1.36	0.00	0.50	0.50
Meningeal Cells, donor2	11573-120E7	45.34	8.80	1.76	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	54.04	13.69	0.82	0.00	0.08	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.08	9.98	0.86	0.29	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.68	7.65	1.11	0.00	0.20	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	39.42	6.57	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	13.08	7.85	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.03	5.74	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	42.57	10.80	1.69	0.00	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	23.12	6.53	1.51	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	43.51	10.55	1.54	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.84	5.84	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	36.62	8.59	0.82	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	35.32	8.03	2.08	0.00	0.55	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	57.99	8.92	1.86	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	41.45	5.92	2.76	0.13	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	50.45	6.83	0.89	0.00	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	39.06	5.76	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	50.33	10.99	1.06	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	43.78	4.69	1.56	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	5.81	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	35.00	9.55	1.86	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	46.04	6.01	1.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	27.53	6.21	1.30	0.07	0.07	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	125.58	12.15	4.05	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	82.01	6.65	5.91	0.25	0.25	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	68.90	8.54	7.36	0.29	0.88	2.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	57.65	6.20	2.79	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	55.80	8.50	7.68	0.21	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	64.85	9.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	69.82	8.26	4.25	0.00	0.50	2.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	84.72	13.03	8.38	0.00	0.93	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	63.81	7.32	6.30	0.00	0.81	1.63
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	61.77	9.11	5.54	0.00	2.38	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	102.62	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	31.86	3.54	4.42	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	57.37	9.12	5.32	0.00	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	59.22	11.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	45.84	4.88	4.88	0.00	0.64	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	40.52	18.42	5.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	36.06	5.37	1.79	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	58.68	18.44	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	39.89	4.77	2.26	0.00	0.25	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	49.43	8.32	4.75	0.24	0.71	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	63.03	9.95	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	35.92	3.68	1.61	0.00	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	49.01	5.89	4.42	0.21	0.00	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	37.30	3.67	2.04	0.00	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	38.19	4.72	2.79	0.00	0.43	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	60.24	8.22	6.67	0.22	0.67	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	34.82	3.29	3.50	0.22	0.66	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	70.97	7.10	5.07	0.00	0.51	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	69.59	13.26	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	42.40	5.98	2.17	0.27	0.82	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	67.34	6.47	7.06	0.29	0.88	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	81.77	11.99	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	32.68	3.84	0.96	0.00	0.48	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	70.04	7.20	4.80	0.40	0.40	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	75.42	8.23	2.74	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	45.55	3.50	2.50	0.50	1.50	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	73.39	16.31	2.04	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	51.67	7.01	1.31	0.44	0.44	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	81.67	11.04	3.31	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	108.87	7.68	1.92	0.00	0.00	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	64.71	9.92	2.98	0.99	0.25	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	79.33	11.83	4.18	0.70	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	165.74	22.10	2.21	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	62.56	8.55	1.71	1.03	0.68	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	94.09	7.88	3.50	0.44	0.44	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	86.29	10.65	2.13	0.36	0.36	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	69.58	9.26	2.81	0.28	1.12	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	76.89	8.31	2.49	1.25	0.42	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	101.40	7.58	1.17	0.00	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	67.87	9.05	3.62	1.21	1.51	1.81
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	78.47	6.26	6.68	2.09	0.42	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	158.81	21.66	7.22	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	52.64	3.69	2.77	0.00	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	91.06	7.40	5.12	1.14	0.00	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	71.03	8.43	3.18	0.14	0.41	2.35
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	63.23	4.15	2.33	0.52	0.52	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	100.38	8.58	6.43	1.29	0.86	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	91.47	10.80	5.08	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	77.66	8.01	4.00	0.53	0.00	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	59.57	7.48	3.89	0.00	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	48.45	6.50	1.98	0.00	0.28	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	58.92	5.41	0.00	0.64	0.32	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	78.94	5.97	4.86	0.22	0.44	3.76
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	69.39	11.76	2.28	0.00	0.00	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	62.79	7.39	3.41	0.28	1.14	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	65.38	8.85	3.20	0.25	0.25	2.70
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	46.92	11.73	2.61	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	54.10	9.70	2.06	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	60.26	8.07	2.88	0.29	0.58	2.88
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	80.78	9.07	8.66	0.00	0.41	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	43.18	7.74	2.38	0.00	0.60	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	1.78	0.00	0.00	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	58.49	6.57	3.94	0.00	0.33	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	6.31	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	23.33	4.15	3.16	0.00	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	30.73	2.79	1.86	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	38.68	4.88	3.00	0.38	0.75	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	36.49	6.13	2.13	0.27	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	46.03	8.03	2.38	0.00	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	23.58	0.74	2.21	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	42.14	3.66	2.93	0.00	1.47	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	48.22	6.22	3.11	0.00	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	40.08	4.81	3.21	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	3.86	7.73	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	35.35	6.06	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	33.73	5.06	4.22	0.42	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	43.58	5.45	4.09	1.36	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	48.32	4.45	3.18	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	66.41	3.24	4.86	1.62	0.81	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	3.02	3.02	0.00	1.51	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	0.00	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	84.82	3.26	16.31	6.52	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	46.75	6.89	0.22	0.00	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	31.88	9.93	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	4.00	0.00	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.35	1.25	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	34.42	7.23	0.76	0.00	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	41.49	15.96	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	213.17	27.56	1.84	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.35	0.00	1.26	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	10.23	3.72	0.23	0.23	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.27	2.43	0.27	0.27	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.75	4.84	2.52	0.21	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	545.60	44.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.93	6.45	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.59	1.89	2.98	0.00	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.67	1.81	0.45	0.00	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.90	1.96	1.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	45.38	6.38	2.19	0.00	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	4.77	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	0.60	1.20	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	71.54	9.19	4.27	0.66	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.34	0.98	0.65	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	53.44	7.23	1.76	0.18	1.06	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	3.52	1.41	1.41	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	1.84	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.25	1.93	0.32	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	55.18	6.55	1.72	0.00	1.03	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	725.66	101.14	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	41.22	5.57	1.78	0.22	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	7.62	1.27	0.85	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.80	4.03	2.14	0.24	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.30	2.58	0.86	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	758.33	135.42	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.66	3.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	28.40	6.76	1.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	1.98	0.40	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	2.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.46	5.68	1.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.12	3.58	0.65	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.25	2.61	0.44	0.00	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	40.71	4.52	0.90	0.00	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	0.88	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	1.99	1.33	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	10.91	2.98	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.59	1.91	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.68	3.33	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	40.67	6.41	2.43	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	1.36	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	510.95	25.55	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.88	3.66	1.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.07	3.46	0.94	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.28	2.42	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	2.37	1.58	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	75.95	15.87	4.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	318.65	40.46	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	44.97	7.21	1.12	0.00	0.75	0.12
Myoblast, donor2	11322-117D8	37.02	6.71	2.30	0.00	0.00	0.58
Myoblast, donor3	11398-118D3	49.94	9.08	1.18	0.00	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	62.46	7.00	8.61	1.02	1.31	0.44
Natural Killer Cells, donor1	11230-116C6	107.94	23.06	31.06	0.92	8.61	7.38
Natural Killer Cells, donor2	11311-117C6	71.77	18.70	23.22	1.51	3.02	6.63
Natural Killer Cells, donor3	11387-118C1	83.74	16.56	23.56	0.92	3.31	6.44
Neural stem cells, donor1	11275-116H6	60.61	14.15	8.35	0.73	0.73	0.00
Neural stem cells, donor2	11352-117H2	55.84	28.88	1.93	0.00	0.00	1.93
Neurons, donor1	11494-119E9	53.48	17.07	2.28	1.14	0.00	0.00
Neurons, donor2	11574-120E8	53.50	16.07	1.76	0.22	0.22	0.00
Neurons, donor3	11655-122E8	23.84	9.04	1.64	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	250.56	22.27	51.97	1.86	10.21	13.92
Neutrophils, donor2	11314-117C9	156.54	20.29	37.69	5.80	8.70	20.29
Neutrophils, donor3	11390-118C4	390.33	22.60	48.26	1.22	12.22	22.60
Nucleus Pulposus Cell, donor1	11252-116F1	54.14	7.36	4.75	0.00	0.24	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	25.40	5.86	2.93	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	21.66	5.21	1.20	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	16.24	3.44	3.17	0.14	0.41	0.28
Olfactory epithelial cells, donor2	11934-125I8	22.44	4.20	3.76	0.29	0.72	0.14
Olfactory epithelial cells, donor3	11935-125I9	24.52	2.27	2.84	0.34	0.45	0.11
Olfactory epithelial cells, donor4	11936-126A1	38.57	4.48	2.05	0.00	0.19	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	43.33	3.61	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	47.22	7.44	2.34	0.00	0.64	0.43
Osteoblast - differentiated, donor2	11353-117H3	18.29	3.43	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	26.69	8.07	1.86	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	33.22	7.43	1.95	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	35.82	10.53	0.00	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	36.97	6.04	0.18	0.00	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	47.59	8.17	1.10	0.00	0.34	0.08
Pericytes, donor1	11491-119E6	54.97	12.24	2.67	0.11	0.33	0.11
Pericytes, donor2	11571-120E5	40.52	9.05	4.53	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	37.64	10.78	0.81	0.00	0.20	0.20
Perineurial Cells, donor1	11499-119F5	35.49	8.25	1.24	0.00	0.23	0.11
Perineurial Cells, donor2	11579-120F4	39.84	6.72	1.84	0.09	0.09	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	148.21	27.73	39.20	1.27	5.74	12.75
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	74.68	10.28	25.22	0.98	3.92	5.88
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	78.04	14.49	19.02	0.78	2.85	5.44
Placental Epithelial Cells, donor1	11278-116H9	42.81	8.61	0.72	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	18.85	5.54	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	28.27	4.32	1.37	0.00	0.39	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	24.37	6.01	0.63	0.00	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	55.34	8.25	3.00	0.00	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	29.89	6.66	0.39	0.13	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	37.15	8.78	1.58	0.00	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	56.37	12.25	2.66	0.00	0.32	0.11
Preadipocyte - omental, donor2	11329-117E6	69.40	10.91	2.62	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	51.57	9.45	1.29	0.00	0.29	0.43
Preadipocyte - perirenal, donor1	11469-119C2	26.58	4.92	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	66.64	11.36	2.76	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	53.83	9.92	1.42	0.18	0.53	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	43.25	4.60	2.04	0.00	0.85	0.00
Preadipocyte - visceral, donor1	11280-116I2	66.41	10.43	2.33	0.28	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	52.92	9.20	0.92	0.00	0.46	1.38
Preadipocyte - visceral, donor3	11429-118G7	36.89	7.31	1.99	0.00	0.63	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	50.99	10.26	1.51	0.00	0.75	0.30
Prostate Epithelial Cells, donor2	11331-117E8	41.98	8.94	0.81	0.14	0.27	0.14
Prostate Epithelial Cells, donor3	11404-118D9	29.95	3.43	0.37	0.00	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	53.31	8.43	1.03	0.00	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	44.29	9.50	1.79	0.00	0.72	0.18
Prostate Stromal Cells, donor3	11405-118E1	39.00	6.47	2.50	0.00	0.42	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	33.58	10.58	0.00	0.00	0.36	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	28.21	4.64	0.62	0.00	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	25.87	5.58	1.52	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	27.03	5.69	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	36.74	5.19	1.06	0.11	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	32.00	5.45	1.36	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	28.70	7.55	0.67	0.27	0.27	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	34.19	5.33	0.44	0.00	0.89	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	30.61	7.99	2.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	37.86	8.80	2.64	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	23.20	7.52	3.13	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	25.52	4.99	1.94	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	40.53	8.59	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.02	3.80	0.42	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	26.61	5.79	0.77	0.00	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	27.22	6.22	0.78	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	53.44	7.96	1.71	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	21.61	6.17	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	59.97	7.28	2.26	0.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	76.04	8.42	2.00	0.27	0.40	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	28.59	1.79	0.89	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	59.99	11.56	2.20	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	59.17	9.86	1.74	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	51.62	8.84	0.39	0.13	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	31.78	6.16	0.40	0.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	40.04	8.92	0.11	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	50.24	8.06	0.62	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	33.22	6.18	0.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	43.45	7.63	0.92	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	26.01	5.34	0.41	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	30.25	4.69	0.61	0.15	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	32.97	9.14	0.36	0.00	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.40	5.16	0.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	31.77	7.73	0.11	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	27.44	4.87	0.89	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	21.22	6.50	0.19	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	34.10	6.80	0.56	0.00	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	48.29	7.33	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.38	7.03	0.40	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	31.34	7.59	0.39	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	36.09	8.98	0.76	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	33.96	5.02	0.32	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	26.63	4.48	0.56	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	35.21	6.67	0.34	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	33.73	6.38	0.73	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.96	4.78	0.25	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	29.15	7.79	0.81	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	26.18	7.31	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	32.14	5.75	0.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	33.21	8.18	0.00	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.50	6.84	0.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	28.09	7.96	0.66	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	38.02	5.43	0.42	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	36.74	7.13	0.13	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	39.34	9.20	0.17	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	39.33	7.33	0.19	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	28.54	7.91	0.34	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	35.12	7.00	0.14	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	37.76	4.43	0.33	0.00	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	21.30	5.79	0.17	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.22	7.99	0.59	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	29.05	5.33	0.27	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	34.01	7.60	0.69	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	27.86	6.43	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	43.53	6.05	0.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	25.99	5.09	0.28	0.00	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	40.53	6.64	1.05	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	45.94	8.16	1.81	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	29.74	5.87	0.73	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	79.76	10.19	1.46	0.15	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.20	4.87	1.22	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	32.85	3.62	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.92	4.30	0.45	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	42.24	7.19	0.90	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	67.18	9.09	1.30	0.12	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.98	2.99	1.49	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	44.47	6.01	0.60	0.60	0.00	0.60
Schwann Cells, donor1	11498-119F4	25.20	7.90	0.56	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	10.21	17.01	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.63	6.57	0.22	0.00	0.22	0.00
Sebocyte, donor1	11220-116B5	93.12	13.69	2.19	0.55	0.00	1.10
Sebocyte, donor2	11301-117B5	53.31	8.73	1.38	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	33.80	4.53	0.62	0.00	0.21	0.21
Sertoli Cells, donor1	11255-116F4	36.45	6.63	6.63	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	53.66	2.82	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	66.07	17.42	2.38	0.00	0.09	0.18
Skeletal Muscle Cells, donor2	11358-117H8	18.79	5.78	1.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	29.26	7.52	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	28.28	8.33	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	23.63	6.09	0.59	0.00	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	27.39	6.00	0.77	0.00	0.15	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.13	8.57	0.63	0.00	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	29.39	6.56	1.28	0.14	0.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	40.97	6.94	0.89	0.00	0.10	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	50.64	10.36	1.60	0.08	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.06	7.24	1.45	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.13	3.99	2.89	0.14	0.28	0.00
Skin - palm, donor1	10286-104F7	185.34	26.86	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.83	3.32	0.86	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.09	7.36	0.00	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.80	2.60	1.04	0.00	0.39	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	44.07	5.56	1.39	0.00	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	37.41	3.80	0.84	0.14	0.84	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	67.24	13.53	1.48	0.63	0.00	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	47.07	5.62	0.75	0.00	0.22	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	22.53	4.94	0.93	0.00	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	19.57	6.45	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	53.49	10.58	0.59	0.00	0.59	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	77.13	16.35	2.87	0.22	1.77	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	43.71	11.03	3.94	0.00	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	45.58	4.64	2.32	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	35.03	3.00	2.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	47.64	6.25	2.13	0.00	0.27	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	35.02	9.75	0.89	0.00	0.66	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	37.00	7.30	2.82	0.00	0.00	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	39.07	6.51	0.65	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	53.75	8.27	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.88	5.55	0.71	0.00	0.14	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	50.92	12.20	1.46	0.33	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	36.53	7.61	1.83	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	48.49	7.83	2.53	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	18.36	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.50	3.81	1.43	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	39.52	7.82	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.42	5.60	1.72	0.00	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.70	7.24	0.84	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	46.56	9.90	2.94	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	40.96	8.62	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	28.99	5.68	1.20	0.00	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	41.65	7.17	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	38.17	5.65	1.65	0.00	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	51.43	10.16	2.72	0.10	0.10	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	71.68	5.92	4.78	0.23	1.59	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	24.15	7.25	1.81	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	38.94	11.92	1.06	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	41.41	10.12	1.73	0.00	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	34.44	7.76	1.88	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	56.31	6.09	3.55	0.00	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	48.10	9.35	2.41	0.30	0.75	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	31.51	6.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	146.02	117.59	12.92	1.29	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	54.41	11.63	3.26	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	44.93	7.07	2.52	0.00	0.00	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	34.79	3.13	2.51	0.00	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	38.05	6.19	1.47	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	44.74	11.25	1.92	0.08	0.33	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.50	5.61	2.80	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	42.31	7.92	0.72	0.00	0.14	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	35.18	5.61	1.02	0.00	0.51	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.19	3.76	1.50	0.00	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	39.69	6.15	1.12	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	35.86	6.45	1.17	0.00	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.52	1.43	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	37.19	5.63	0.49	0.00	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	43.53	5.52	2.43	0.00	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.65	4.39	2.34	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	23.71	3.30	1.17	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	23.54	3.17	0.26	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	29.01	3.35	3.72	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	35.57	6.47	1.44	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.13	4.83	0.85	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.94	3.54	0.39	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	24.63	4.32	1.02	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	21.96	2.80	1.60	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	17.97	4.18	1.25	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	25.21	5.04	1.83	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	47.13	6.40	2.36	0.00	1.01	0.34
Synoviocyte, donor2	11368-117I9	40.73	5.03	2.51	0.00	0.34	0.17
Synoviocyte, donor3	11440-118H9	25.47	3.35	1.79	0.00	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	43.24	13.22	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	7.93	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	26.63	8.80	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	47.17	6.09	0.86	0.00	0.00	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	29.38	1.55	1.93	0.00	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	33.21	3.44	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	74.68	11.32	2.09	0.00	0.49	0.86
Urethra, donor2	10319-105A4	145.67	44.96	3.60	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	35.33	4.25	1.33	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	21.63	5.21	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	21.09	1.83	0.46	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	37.45	2.90	0.45	0.00	0.22	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	662.89	39.15	17.80	8.90	6.23	103.21
Whole blood (ribopure), donor090309, donation2	12180-129A2	729.10	60.04	20.01	8.58	2.86	85.78
Whole blood (ribopure), donor090309, donation3	12181-129A3	415.50	27.38	13.69	5.48	7.53	48.60
Whole blood (ribopure), donor090325, donation1	12176-128I7	392.55	30.30	22.73	6.89	4.82	35.81
Whole blood (ribopure), donor090325, donation2	12177-128I8	309.69	26.15	17.43	6.39	1.74	23.82
Whole blood (ribopure), donor090612, donation1	12182-129A4	509.17	42.69	18.74	2.08	4.16	82.26
Whole blood (ribopure), donor090612, donation2	12183-129A5	478.17	39.47	18.36	4.59	5.51	79.85
Whole blood (ribopure), donor090612, donation3	12184-129A6	440.02	42.91	15.52	0.91	3.65	58.43
Wilms' tumor cell line:G-401	10809-111A8	22.08	7.28	0.37	0.00	0.25	0.12
Wilms' tumor cell line:HFWT	10597-108E3	60.72	17.60	2.64	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	16.20	9.22	0.28	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	62.00	35.13	12.40	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	67.82	11.98	5.10	0.76	1.02	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	102.16	25.07	3.02	0.70	0.46	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	98.77	22.55	11.63	3.68	1.42	1.42
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	153.47	17.14	4.90	8.71	0.82	2.45
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	95.85	21.36	6.46	2.53	2.81	7.03
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	116.95	20.51	8.25	1.48	1.90	2.11
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	57.98	16.06	15.79	5.72	2.18	7.62
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	35.69	14.98	1.76	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	65.75	18.78	13.48	4.90	0.82	5.31
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	55.14	14.76	6.60	0.00	0.39	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	33.12	6.99	1.66	0.18	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	39.01	7.80	0.00	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	96.44	15.80	15.10	5.11	2.79	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	70.94	18.12	2.59	0.26	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	69.26	20.16	3.21	0.29	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	40.90	22.31	1.39	0.00	0.46	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	66.62	16.45	5.76	0.00	0.82	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	19.03	8.59	0.00	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	53.77	12.80	0.43	0.00	0.43	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.69	13.04	1.52	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	69.08	21.90	1.68	0.24	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	56.13	14.26	1.11	0.00	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	45.36	17.34	0.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	68.75	20.44	5.57	0.00	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	107.72	9.79	2.64	3.77	2.26	34.28
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	276.07	17.45	42.74	5.23	8.72	53.21
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	110.59	24.37	7.50	3.75	1.87	28.12
adenocarcinoma cell line:IM95m	10796-110I4	19.08	6.12	0.47	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	94.47	12.72	4.96	0.00	0.47	0.31
adipose, donor1	10184-103D4	72.13	18.18	4.10	0.59	0.59	0.59
adipose, donor2	10185-103D5	10.54	4.87	2.84	1.22	0.00	0.00
adipose, donor3	10186-103D6	18.52	14.43	11.16	1.09	1.63	0.27
adipose, donor4	10187-103D7	26.87	39.87	10.40	0.87	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	44.35	26.67	0.16	0.00	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.62	11.61	0.40	0.00	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.87	8.22	0.00	0.00	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	59.82	9.27	0.00	0.46	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	41.59	12.85	1.35	0.00	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	50.97	9.72	0.00	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	43.87	17.79	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	133.22	16.83	1.82	0.00	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	23.56	4.20	1.94	0.00	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	78.31	13.88	4.71	0.13	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	40.82	11.03	0.88	0.22	0.00	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	39.75	14.70	1.34	0.00	0.33	0.00
aorta, adult, pool1	10052-101G7	35.11	8.43	0.78	0.00	0.20	0.78
appendix, adult	10189-103D9	105.96	20.96	6.21	0.39	0.39	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	50.90	7.22	4.13	0.34	0.34	0.00
artery, adult	10190-103E1	52.99	8.15	4.08	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	110.10	14.49	5.36	0.14	0.43	0.14
b cell line:RPMI1788	10427-106D4	45.95	8.77	3.27	0.00	0.30	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	43.56	6.10	0.83	0.00	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	74.52	16.77	1.29	0.00	0.50	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	30.80	7.87	0.33	0.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	58.16	13.98	3.91	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	89.85	12.39	4.02	0.11	0.33	0.54
blood, adult, pool1	10053-101G8	172.74	2.21	11.07	0.00	0.00	46.51
bone marrow stromal cell line:StromaNKtert	10686-109F2	53.95	9.42	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	51.96	16.87	5.40	0.00	0.67	0.67
brain, adult, donor1	10084-102B3	41.00	12.30	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	71.49	17.59	3.12	0.00	0.45	0.33
brain, fetal, pool1	10085-102B4	37.40	8.01	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	74.66	24.12	1.98	0.00	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	94.37	22.97	0.37	0.00	0.12	0.12
breast, adult, donor1	10080-102A8	22.10	5.05	0.00	0.00	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.33	20.07	0.76	0.25	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	45.46	12.99	6.80	0.00	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	59.86	14.50	2.53	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	20.58	6.78	0.48	0.00	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	41.37	7.52	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	32.16	10.94	0.33	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	40.88	8.24	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	56.96	15.70	1.86	1.33	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	50.66	12.66	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	115.46	20.41	2.34	0.17	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	30.57	14.52	2.29	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	31.50	8.42	4.03	0.00	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	128.18	29.13	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	338.41	41.42	2.35	0.00	0.43	0.00
cerebellum, adult, pool1	10083-102B2	67.95	12.76	2.76	0.34	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	123.71	22.42	3.32	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	68.58	21.18	4.29	0.00	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	54.09	19.00	1.46	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	48.89	7.05	1.58	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	117.16	8.78	2.15	0.00	0.33	0.00
cervix, adult, pool1	10013-101C4	124.41	23.41	7.35	0.00	0.31	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	39.15	8.36	0.14	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	13.06	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	56.17	12.80	0.50	0.00	0.12	0.12
choriocarcinoma cell line:SCH	10785-110H2	27.72	7.02	0.37	0.00	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	36.53	11.15	0.24	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	42.17	11.40	0.28	0.00	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	62.44	7.46	1.29	0.00	0.20	0.00
chorionic membrane cells, donor3	12240-129G8	48.90	9.34	2.75	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	37.36	16.16	6.06	2.02	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	53.79	10.76	5.38	0.00	0.58	3.84
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	51.74	10.56	6.34	1.27	0.63	20.91
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	30.05	7.96	0.77	0.00	0.00	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	28.30	7.74	0.48	0.00	0.24	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	35.43	10.38	0.41	0.00	0.00	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	63.31	15.31	0.29	0.00	0.00	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	180.35	26.32	9.12	0.78	1.82	12.25
clear cell carcinoma cell line:JHOC-5	10638-108I8	27.20	9.83	0.23	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	43.38	9.89	0.52	0.00	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	38.99	10.80	0.92	0.00	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	94.64	19.76	6.46	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	20.23	8.33	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	103.87	12.46	3.53	0.00	0.71	0.82
colon, fetal, donor1	10070-101I7	41.41	6.18	3.71	0.62	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	334.60	119.17	9.17	0.00	0.00	55.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	49.29	9.77	3.40	1.70	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	41.81	8.00	2.26	0.15	0.45	1.81
cord blood derived cell line:COBL-a untreated	10449-106F8	59.37	7.33	2.54	0.71	0.14	1.13
corpus callosum, adult, pool1	10042-101F6	157.00	26.98	7.19	0.22	0.33	0.22
cruciate ligament, donor2	10295-104G7	102.12	33.23	7.29	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	28.89	7.22	2.41	0.00	0.00	1.61
diencephalon, adult	10193-103E4	51.84	13.92	1.20	0.00	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	46.61	14.70	3.67	0.00	0.46	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	98.47	21.54	3.33	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	57.29	8.43	1.20	0.00	0.24	0.00
ductus deferens, adult	10196-103E7	84.22	16.94	2.49	0.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	41.77	5.76	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	68.42	12.51	3.68	0.00	0.74	1.47
dura mater, adult, donor1	10041-101F5	113.81	19.99	15.20	0.83	2.48	1.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	98.60	6.66	2.00	0.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	56.03	11.75	0.29	0.00	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	78.93	17.27	1.85	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	64.78	18.47	0.61	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	91.39	21.92	1.54	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	124.78	28.90	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	80.78	21.12	2.68	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	55.28	17.58	0.91	0.18	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	32.32	6.59	0.32	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	133.06	11.67	2.22	0.00	0.22	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	93.93	11.44	1.65	0.00	0.77	0.44
epididymis, adult	10197-103E8	66.56	20.72	4.60	0.21	0.42	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	40.09	10.82	0.53	0.00	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	26.35	12.58	0.39	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	61.20	16.77	0.79	0.00	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	51.28	13.09	0.30	0.00	0.00	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	58.93	15.91	0.56	0.00	0.22	0.11
esophagus, adult, pool1	10015-101C6	83.67	9.98	2.55	0.00	0.21	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	241.46	23.04	16.53	1.75	3.13	3.51
eye - muscle inferior rectus, donor1	10272-104E2	91.75	26.56	9.66	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	63.13	14.73	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	87.80	22.32	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	66.50	22.93	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	51.01	18.95	10.20	0.00	0.00	4.37
eye, fetal, donor1	10054-101G9	43.73	10.42	3.81	0.25	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	34.24	10.13	1.41	0.00	0.13	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	33.95	9.50	0.24	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	109.68	24.86	3.85	0.09	0.00	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	52.84	13.21	0.00	0.00	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	29.63	9.42	0.09	0.00	0.09	0.18
gall bladder, adult	10198-103E9	72.43	15.45	3.38	0.00	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	110.59	25.77	10.20	3.76	4.29	3.76
gamma delta positive T cells, donor2	11938-126A3	115.41	21.66	14.57	1.87	1.12	16.43
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.32	5.49	0.84	0.00	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	56.28	13.93	0.19	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	57.71	20.00	0.66	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	10.98	8.24	1.83	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	46.83	8.00	1.37	0.23	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	35.80	6.08	0.23	0.11	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	58.78	14.56	1.40	0.14	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	87.55	8.23	2.74	0.00	0.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	21.43	7.39	0.63	0.00	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.02	6.46	0.42	0.28	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	32.89	4.75	1.55	0.33	0.22	0.11
glioma cell line:GI-1	10413-106B8	53.89	7.61	3.22	0.00	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	37.90	12.39	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	204.06	29.05	3.66	0.00	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	26.01	6.85	4.11	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	22.92	4.80	1.60	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	225.14	70.97	2.45	0.00	0.00	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	109.28	32.79	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	67.95	20.91	10.45	5.23	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	30.08	4.48	1.28	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	12.86	8.72	1.84	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	7.32	5.03	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.86	3.86	0.64	0.00	1.29	0.00
hIPS, biol_rep1	14380-156B6	4.31	10.06	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	5.49	7.54	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	20.97	16.55	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	43.39	5.75	2.01	0.29	0.86	3.16
heart - mitral valve, adult	10205-103F7	70.26	14.65	1.49	0.00	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	78.44	18.04	2.88	0.00	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	98.25	15.82	1.67	0.83	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	37.75	6.73	1.22	0.00	0.41	1.22
heart, adult, diseased, donor1	10051-101G6	54.93	5.96	2.55	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	91.99	11.50	2.53	0.23	0.00	1.38
heart, fetal, pool1	10046-101G1	112.85	16.02	4.93	0.72	0.72	1.85
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.99	3.09	0.62	0.00	0.00	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	58.27	17.84	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	56.24	7.07	0.99	0.00	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	54.98	8.37	0.49	0.00	0.00	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	61.34	8.29	0.40	0.10	0.40	0.00
hepatoma cell line:Li-7	10484-107A7	43.71	5.45	1.22	0.00	0.44	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	68.14	14.57	1.91	0.00	0.20	0.20
hippocampus - adult, donor10196	10169-103B7	47.32	8.52	0.00	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	148.18	13.88	3.27	0.00	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	8.96	15.93	0.50	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	24.32	10.93	1.06	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	29.30	7.32	0.61	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.88	5.30	0.39	0.59	0.20	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	27.17	5.08	0.00	0.00	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	14.10	5.64	3.38	1.13	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.18	6.71	3.10	0.52	0.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	30.37	7.21	4.18	0.76	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	20.73	13.14	3.80	1.17	0.88	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	25.64	12.93	2.37	1.51	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.02	5.84	3.75	1.25	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	24.39	9.23	4.03	0.47	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	22.50	6.91	3.54	0.80	0.64	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.87	5.39	0.67	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	30.05	7.04	1.10	0.94	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.56	5.90	1.97	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	41.89	12.22	1.75	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	27.68	9.55	4.58	1.34	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	22.68	6.11	3.92	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	18.49	6.00	5.00	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	17.71	8.48	4.14	0.57	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	16.82	9.09	1.36	0.91	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.66	7.83	2.19	0.94	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.84	5.39	5.06	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	20.32	7.55	3.19	1.16	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	18.83	6.58	5.68	1.49	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	26.05	5.91	0.74	0.55	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	22.82	4.56	0.00	0.57	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	27.36	6.94	1.22	0.41	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	28.52	7.75	2.11	0.00	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	18.69	6.33	1.27	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	20.88	9.99	1.82	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	23.79	10.34	2.07	1.03	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.28	7.97	0.66	1.33	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.57	8.98	2.82	1.03	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	26.08	6.39	3.58	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	23.47	7.57	2.27	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.82	4.03	2.69	1.01	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	28.50	3.62	1.45	0.24	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	28.08	7.13	0.89	0.89	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	24.39	3.41	0.98	0.49	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	25.37	10.39	3.67	0.92	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	152.90	22.77	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	30.45	11.25	2.98	0.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	27.91	12.04	2.19	1.64	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	18.46	9.05	1.45	0.00	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	20.64	8.19	2.85	1.07	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	5.97	1.19	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	33.45	9.34	4.88	1.49	0.95	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.39	2.16	2.16	0.81	0.27	0.00
immature langerhans cells, donor1	11904-125F5	34.14	15.26	5.57	0.00	0.48	0.73
immature langerhans cells, donor2	11905-125F6	26.93	10.30	0.79	0.00	0.79	0.79
insula, adult, pool1	10039-101F3	125.01	34.64	3.03	0.00	0.28	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	26.01	1.95	1.95	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	81.80	14.42	2.60	0.00	0.40	0.40
kidney, fetal, pool1	10045-101F9	74.20	15.35	7.29	0.42	0.64	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	134.64	30.39	7.39	0.28	0.71	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	27.37	5.94	1.52	0.00	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	48.81	10.83	0.92	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	22.34	2.72	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	12.14	3.03	1.52	0.00	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	34.75	9.30	0.55	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	31.25	5.75	3.59	0.36	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	23.37	4.89	0.54	0.00	1.09	0.00
leiomyoma cell line:15425	10571-108B4	34.48	10.20	2.43	0.00	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	19.05	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	6.27	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	106.49	9.09	5.31	0.71	1.06	6.97
liposarcoma cell line:KMLS-1	10782-110G8	37.02	5.94	1.87	0.00	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	35.46	9.87	1.95	0.24	0.37	0.12
liver, adult, pool1	10018-101C9	50.08	6.48	1.13	0.00	0.16	0.49
liver, fetal, pool1	10086-102B5	5.64	1.88	0.00	0.00	0.00	3.76
locus coeruleus - adult, donor10196	10182-103D2	69.27	15.02	3.79	0.00	0.15	0.44
locus coeruleus, adult, donor10252	10165-103B3	130.66	14.76	1.85	0.00	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	23.42	7.05	0.85	0.00	1.13	0.00
locus coeruleus, newborn, donor10223	10362-105F2	54.26	13.46	2.94	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	53.01	13.84	0.69	0.00	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	70.32	11.03	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	29.13	9.49	0.66	0.00	0.13	0.00
lung, adult, pool1	10019-101D1	100.05	12.05	4.84	0.35	0.35	0.95
lung, fetal, donor1	10068-101I5	148.13	40.53	13.98	2.00	1.14	5.14
lung, right lower lobe, adult, donor1	10075-102A3	34.82	8.71	5.96	0.92	0.00	0.92
lymph node, adult, donor1	10077-102A5	26.51	4.73	9.47	0.47	1.42	1.42
lymphangiectasia cell line:DS-1	10727-110A7	27.40	4.16	0.22	0.00	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	77.88	9.66	4.38	2.11	0.45	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	189.44	12.74	3.40	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	68.82	10.21	0.44	0.00	0.00	0.89
mature adipocyte, donor2	12232-129F9	81.97	10.17	1.25	0.00	0.21	0.21
mature adipocyte, donor3	12233-129G1	64.24	10.19	1.66	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	66.59	13.42	2.37	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	80.77	16.44	1.43	0.00	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	36.10	13.54	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	145.10	24.28	2.02	0.00	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	21.92	9.53	0.64	0.00	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	87.43	18.77	2.99	0.00	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	63.96	16.88	2.87	0.17	0.68	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	156.20	26.95	1.06	0.00	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	1.93	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	430.61	172.24	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	33.38	10.77	1.79	0.00	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	35.69	7.14	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	159.76	15.79	3.87	0.31	0.31	0.31
medulla oblongata, adult, pool1	10038-101F2	121.95	20.65	6.37	0.16	0.90	0.41
medulla oblongata, newborn, donor10223	10361-105F1	42.01	8.68	2.43	0.35	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	53.14	18.38	1.11	0.00	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	19.69	4.89	0.24	0.00	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	56.49	5.46	1.15	0.00	0.14	0.00
melanoma cell line:G-361	10465-106H6	56.46	8.14	1.63	0.00	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	31.30	5.25	0.54	0.00	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	83.71	22.91	3.52	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	95.39	21.26	1.56	0.26	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	54.32	8.13	1.84	0.00	0.00	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	54.72	4.18	2.54	0.18	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	38.51	5.38	0.83	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	47.76	4.21	1.55	0.14	0.00	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	59.31	6.93	1.35	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	51.36	7.63	1.39	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	61.45	9.27	1.03	0.00	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	51.18	5.87	2.07	0.00	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	41.78	6.90	0.53	0.00	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.89	7.29	1.22	0.00	0.27	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	54.91	5.55	1.56	0.00	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	57.31	7.58	2.31	0.00	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	44.42	6.37	1.11	0.00	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	41.89	6.98	1.05	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	38.79	4.49	0.41	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	34.87	5.39	0.36	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	32.28	3.62	1.34	0.00	0.10	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.95	5.02	1.37	0.23	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	55.38	9.23	0.42	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.17	4.93	1.05	0.00	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.19	4.99	1.75	0.09	0.18	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	43.07	4.79	0.37	0.00	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	31.48	4.86	2.00	0.00	0.29	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.52	4.63	0.42	0.00	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	41.10	5.94	0.46	0.00	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	36.83	9.72	1.02	0.00	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	32.46	7.33	1.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	37.28	6.47	1.85	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	40.01	10.83	1.18	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	34.52	7.78	2.03	0.00	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.51	6.68	2.36	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	36.14	8.34	3.24	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	47.30	9.23	1.15	0.00	1.15	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.69	7.59	1.56	0.00	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	34.37	6.73	1.68	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	55.73	8.07	1.47	0.00	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	30.54	5.71	0.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	33.57	5.32	2.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	26.63	5.58	3.01	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	8.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	32.48	6.82	0.97	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	8.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.99	2.67	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	20.44	4.91	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.93	4.66	2.33	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	28.81	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.06	6.52	1.19	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	29.24	3.66	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	20.27	6.33	0.00	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	23.11	4.14	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	6.45	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.04	4.89	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	36.54	1.59	0.00	0.00	0.00	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.76	2.95	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.11	2.18	0.94	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	34.75	2.67	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	18.92	3.55	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	23.41	4.82	0.69	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	27.71	1.48	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	1.12	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	5.09	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	20.96	2.01	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	5.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	36.41	7.28	1.82	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.95	5.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.62	2.38	0.99	0.20	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.71	3.89	0.97	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	3.06	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	84.33	17.80	3.87	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	46.78	8.27	0.47	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	27.11	8.34	1.62	0.70	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	37.61	4.52	1.03	0.00	0.21	0.10
mesothelioma cell line:Mero-25	10850-111F4	63.55	14.98	3.18	1.13	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	24.45	11.49	0.49	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	18.16	3.10	1.33	0.00	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	47.57	6.31	1.84	0.79	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	32.00	6.13	1.36	0.00	0.68	0.17
mesothelioma cell line:Mero-84	10855-111F9	37.66	5.06	0.76	0.51	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	33.33	4.76	1.66	0.21	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	26.01	9.77	1.99	0.00	0.33	0.83
mesothelioma cell line:NCI-H226	10846-111E9	23.17	6.70	0.72	0.18	0.18	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	21.01	5.30	1.71	0.34	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	13.49	3.82	1.02	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	17.61	8.16	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	26.28	3.79	0.27	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	37.23	15.74	0.96	0.00	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	35.05	17.22	0.37	0.00	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	43.97	19.20	0.72	0.00	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	48.65	5.55	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.37	3.81	1.06	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	65.42	6.91	1.15	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	30.83	6.09	3.23	0.76	0.57	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	90.18	18.11	2.59	0.00	0.00	0.37
myeloma cell line:PCM6	10474-106I6	48.23	6.13	1.98	0.00	0.00	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	58.34	13.70	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.62	7.65	0.59	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.43	4.79	0.00	0.00	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	38.83	5.74	0.22	0.00	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	34.78	21.53	1.66	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	126.30	35.43	5.52	1.15	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	81.20	28.44	2.06	0.00	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	33.53	4.22	0.21	0.00	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	91.68	18.64	4.29	0.19	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	42.23	8.54	3.80	0.71	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	40.70	9.66	1.74	0.00	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	43.07	9.06	0.81	0.00	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	37.51	12.08	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.96	4.52	1.60	0.27	0.00	0.53
neutrophil PMN, donor1	12133-128D9	327.25	148.75	0.00	0.00	0.00	74.37
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	37.88	9.47	0.00	0.00	18.94
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	73.74	16.57	5.24	0.17	0.17	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	48.03	25.62	0.00	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.40	5.13	0.96	0.00	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	38.89	7.09	2.10	0.00	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	101.99	27.93	3.37	0.00	0.09	0.28
occipital cortex - adult, donor10196	10172-103C1	59.75	16.48	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	164.77	24.69	2.68	0.27	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	43.31	16.38	3.28	0.00	0.00	1.09
occipital lobe, adult, donor1	10076-102A4	51.95	20.47	3.94	0.00	1.05	0.00
occipital lobe, fetal, donor1	10073-102A1	36.90	15.02	2.57	0.00	1.29	0.00
occipital pole, adult, pool1	10036-101E9	100.44	25.62	2.29	0.00	0.16	0.47
olfactory region, adult	10195-103E6	64.00	16.24	2.29	0.00	0.19	0.38
optic nerve, donor1	10277-104E7	68.04	26.01	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	67.78	10.14	0.57	0.00	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	71.30	11.54	0.69	0.14	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	89.57	10.50	2.88	0.34	1.19	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	44.59	7.74	1.50	0.00	0.23	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	29.10	5.88	0.00	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	162.57	27.10	1.87	0.00	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	86.52	14.84	1.48	0.42	0.00	0.42
ovary, adult, pool1	10020-101D2	102.29	20.88	4.11	0.00	0.44	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	30.80	5.87	1.28	0.00	0.37	0.00
pancreas, adult, donor1	10049-101G4	49.85	11.29	1.88	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	23.76	6.15	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	32.88	8.69	1.36	0.00	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	99.51	7.62	15.07	0.33	1.99	0.66
paracentral gyrus, adult, pool1	10035-101E8	93.99	28.19	3.29	0.00	0.18	0.37
parietal cortex, adult, donor10258	10373-105G4	29.36	26.42	0.73	0.00	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	55.49	11.29	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	137.96	21.66	1.43	0.00	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	108.92	25.29	2.11	0.00	0.26	0.62
parietal lobe, fetal, donor1	10072-101I9	34.91	10.67	7.76	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	44.86	10.47	4.11	0.00	0.00	1.12
parotid gland, adult	10199-103F1	120.25	9.25	1.23	0.00	0.62	0.00
penis, adult	10200-103F2	62.84	13.43	4.30	0.54	2.69	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.68	4.83	0.56	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	53.91	9.62	2.77	0.15	0.44	0.29
pineal gland - adult, donor10196	10179-103C8	45.80	13.55	0.65	0.00	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	164.04	24.87	2.96	0.00	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	35.12	18.19	2.51	1.25	0.00	1.88
pituitary gland - adult, donor10196	10180-103C9	73.86	17.20	1.01	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	148.02	28.14	1.04	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	29.79	16.17	2.55	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	72.24	13.44	3.01	0.22	0.54	0.97
plasma cell leukemia cell line:ARH-77	10840-111E3	62.77	8.61	3.18	0.13	1.19	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	47.78	5.14	1.09	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	96.05	20.57	2.32	0.00	0.52	0.43
postcentral gyrus, adult, pool1	10032-101E5	99.12	22.84	1.39	0.00	0.26	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	232.14	75.29	4.18	0.00	0.00	20.91
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	5.51	11.02	0.00	5.51	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	11.74	0.00	0.00	23.47
prostate cancer cell line:DU145	10490-107B4	46.32	13.55	0.58	0.00	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	117.25	20.51	2.72	0.18	0.54	0.18
prostate, adult, pool1	10022-101D4	94.68	15.69	3.08	0.09	0.27	0.27
putamen, adult, donor10196	10176-103C5	103.16	20.77	1.89	0.00	0.47	0.71
putamen, adult, donor10252	10152-102I8	52.94	11.76	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	10.93	3.28	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	50.98	12.32	0.97	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	74.97	14.99	2.25	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	69.53	13.96	0.87	0.00	0.00	0.58
rectum, fetal, donor1	10067-101I4	23.65	5.56	4.17	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	14.63	5.94	0.00	0.21	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	30.65	4.14	4.56	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	96.82	22.36	6.46	0.10	0.40	0.80
retinoblastoma cell line:Y79	10475-106I7	72.23	12.73	2.60	0.26	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	35.53	13.28	0.12	0.00	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	73.11	24.18	1.41	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	60.63	10.61	3.79	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	35.77	6.80	2.59	0.00	0.32	0.49
salivary acinar cells, donor2	11772-123I8	33.32	7.02	1.93	0.00	0.55	0.00
salivary acinar cells, donor3	11773-123I9	80.77	11.25	0.66	0.00	0.00	1.32
salivary gland, adult, pool1	10093-102C3	94.37	17.73	2.86	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	61.97	18.80	1.52	0.17	0.25	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	57.37	15.63	1.06	0.00	0.00	0.35
seminal vesicle, adult	10201-103F3	117.98	20.63	7.41	0.00	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	71.42	10.69	2.43	0.00	1.21	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	33.97	12.08	1.51	0.25	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	37.13	14.05	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	37.88	9.67	2.42	0.00	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	82.90	5.64	2.43	0.00	0.22	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	44.90	6.58	1.94	0.00	0.39	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	59.58	25.54	4.26	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	49.53	10.19	2.52	0.00	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	17.09	1.01	2.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	40.40	11.36	3.16	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	39.36	13.67	1.67	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	55.79	10.40	0.95	0.00	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	32.19	16.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	52.58	16.81	2.14	0.00	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	43.43	6.27	0.32	0.16	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	38.35	12.64	0.87	0.00	0.00	0.22
small intestine, adult, pool1	10024-101D6	165.31	15.05	3.22	0.12	0.84	0.48
small intestine, fetal, donor1	10064-101I1	80.34	9.09	2.70	0.49	0.74	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	55.39	11.28	4.10	0.00	1.03	1.03
smooth muscle, adult, pool1	10048-101G3	63.32	12.15	3.62	0.00	0.78	0.78
somatostatinoma cell line:QGP-1	10781-110G7	30.29	5.90	2.41	0.00	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	66.30	11.24	5.96	0.23	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	156.53	17.74	3.55	0.00	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	27.67	11.76	2.77	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	50.62	12.20	2.44	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	58.32	8.73	4.59	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	35.85	6.27	1.05	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	108.92	12.78	8.04	0.88	0.33	3.19
spleen, fetal, pool1	10044-101F8	107.42	16.45	10.89	1.43	1.19	6.12
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	51.55	11.80	1.86	0.00	0.10	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	69.30	12.15	0.38	0.00	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	56.96	12.23	0.35	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	54.34	14.86	0.00	0.00	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	90.05	19.81	2.59	0.11	0.79	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	29.23	16.52	0.42	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	41.04	5.50	0.00	0.00	0.00	0.42
stomach, fetal, donor1	10062-101H8	64.08	10.68	5.34	0.00	1.07	1.07
submaxillary gland, adult	10202-103F4	63.80	13.10	1.14	0.57	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	152.87	15.79	1.87	0.00	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	11.90	11.38	0.00	0.00	1.03	1.55
substantia nigra, newborn, donor10223	10358-105E7	27.56	8.48	2.83	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	54.79	14.21	1.15	0.46	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	96.72	25.69	4.07	0.00	0.25	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	62.68	12.11	3.56	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	69.45	32.53	1.32	0.44	1.76	0.88
tenocyte, donor1	11763-123H8	49.22	3.49	1.40	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	43.11	6.10	1.53	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	40.03	6.67	2.22	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	35.69	7.99	1.02	0.34	0.34	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	34.07	6.78	1.08	0.00	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	26.04	8.99	0.62	0.00	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.07	7.24	0.00	0.00	0.00	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	40.46	13.24	0.38	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	61.51	12.76	0.22	0.00	0.11	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	24.10	11.40	0.00	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	67.86	17.50	4.19	0.21	0.54	0.64
testis, adult, pool2	10096-102C6	40.15	36.54	0.45	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	55.20	14.35	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	176.29	21.25	1.72	0.16	0.00	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	4.62	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.27	4.61	0.99	0.00	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	35.67	7.48	1.73	0.00	0.58	0.58
throat, adult	10209-103G2	65.41	11.48	3.75	0.50	0.25	1.25
throat, fetal, donor1	10061-101H7	31.99	11.27	7.01	0.30	0.61	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	63.59	12.52	1.39	0.20	0.40	0.00
thymus, adult, pool1	10027-101D9	121.58	20.18	18.69	4.37	1.59	0.80
thymus, fetal, pool1	10043-101F7	139.75	17.66	20.78	6.34	0.73	2.08
thyroid carcinoma cell line:KHM-5M	10776-110G2	32.44	8.11	0.80	0.00	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	44.14	10.48	0.84	0.00	0.28	0.00
thyroid, adult, pool1	10028-101E1	99.19	19.32	7.19	0.00	0.47	0.47
thyroid, fetal, donor1	10060-101H6	22.94	9.23	2.11	0.00	0.00	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	153.98	43.11	9.24	3.08	3.08	0.00
tongue, adult	10203-103F5	59.07	9.07	4.19	0.23	0.47	0.70
tongue, fetal, donor1	10059-101H5	28.77	3.15	1.58	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	143.15	20.44	9.12	0.40	1.60	1.50
trachea, adult, pool1	10029-101E2	79.10	14.23	2.86	0.16	0.16	0.65
trachea, fetal, donor1	10058-101H4	30.78	11.16	1.92	0.00	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	29.05	5.67	0.35	0.00	1.42	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	77.61	12.06	4.26	0.51	0.71	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	79.91	14.89	0.78	0.31	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	64.69	15.22	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.24	6.35	4.23	0.51	0.68	0.42
umbilical cord, fetal, donor1	10057-101H3	27.12	6.26	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	98.11	29.18	10.41	0.34	1.37	0.68
uterus, fetal, donor1	10055-101H1	35.83	5.12	2.56	0.51	0.00	1.54
vagina, adult	10204-103F6	106.62	16.80	1.29	0.00	0.00	0.00
vein, adult	10191-103E2	69.05	14.91	8.77	0.66	0.88	2.19
xeroderma pigentosum b cell line:XPL 17	10563-108A5	49.13	6.14	0.27	0.00	0.27	0.80